DexCare Acquires Mila Health to Deploy AI Patient Scheduling
The Seattle health-tech company will integrate conversational AI agents that call and text patients to book medical appointments across its 57-million-patient network.

DexCare expands AI capabilities with Mila acquisition
Seattle-based DexCare announced it has acquired Mila Health, bringing conversational AI agents into its patient scheduling platform. The deal, whose financial terms were not disclosed, will enable DexCare to deploy AI that calls and texts patients to book medical appointments across the 57 million patients it serves nationwide.
DexCare originally spun out of Providence's digital innovation group ten years ago. The company helps healthcare organizations optimize appointment scheduling by managing patient referral requirements, insurance verification, and scheduling protocols. Its customer base includes Kaiser Permanente, Piedmont, Texas Health Resources, and Tampa General.
Mila Health's technology answers patient questions about appointment availability and qualification requirements. According to the company, its AI agents can be embedded into existing healthcare systems and launched within hours.
Why it matters
Healthcare organizations face persistent staffing challenges for routine administrative tasks like appointment scheduling, while patients increasingly expect instant, digital-first interactions. This acquisition addresses both pressures by automating patient communication at scale—but only if the AI can navigate the complex compliance, accuracy, and integration requirements that make healthcare IT notoriously difficult. DexCare's existing infrastructure and Mila's rapid deployment model suggest a practical path to implementation that standalone AI vendors have struggled to achieve.
Addressing healthcare AI deployment challenges
"Healthcare can't rely on out-of-the-box large language models because they're unpredictable and can't be audited," said Shailu Verma, co-founder and CEO of Mila, in a statement. The acquisition aims to provide healthcare providers and payers with configurable AI agents that can handle tasks they cannot adequately staff.
Matt Blosl, CEO of DexCare, emphasized the infrastructure gap in healthcare AI: "AI solutions are everywhere, but health systems quickly realize that building the infrastructure, scaling the pilot, and managing the agent's boundaries is untenable."
Company backgrounds and funding
DexCare has raised $146 million to date, including a $75 million round in 2023. The company previously acquired Womp, a Bellingham, Washington-based online commerce platform, in 2022. DexCare employs approximately 133 people and ranks No. 43 on the GeekWire 200 index of Pacific Northwest startups.
Mila Health launched in January 2024 under Verma's leadership. Verma previously served as chief product officer of strategy and innovation at UnitedHealth Group and spent five years as a product manager at Amazon Web Services. Mila appears not to have raised venture capital and has 25 employees.
These details were first reported by GeekWire.
This is an original analysis by the Omega editorial team. Source reporting: AI Watch.
Want systems like this working for your business?
Book a Call

